Download PDF
Thromb Haemost 1997; 78(01): 065-069
DOI: 10.1055/s-0038-1657502
Platelet-leukocyte-endothelial cell cross-talk
Schattauer GmbH Stuttgart

Vascular Biology of CD36: Roles of this New Adhesion Molecule Family in Different Disease States

Laurent Daviet
1   INSERM Unit 331, Faculty of Medicine RTH Laënnec, Lyon, France
,
John L McGregor
1   INSERM Unit 331, Faculty of Medicine RTH Laënnec, Lyon, France
2   Stanford Medical School, Division of Hematology (S161), Stanford, CA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Okumura T, Jamieson GA. Platelet glycocalicin-orientation of glycoproteins of the human platelet surface. J Biol Chem 1976; 251: 5944-5949
    PubMedGoogle Scholar
  • 2 Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum-parasitized erythrocytes. Cell 1989; 58: 095-101
    CrossrefPubMedGoogle Scholar
  • 3 Tao N, Wagner SJ, Lublin DM. CD36 is palmitoylated on both N-and C-terminal cytoplasmic tails. J Biol Chem 1996; 271: 22315-22320
    CrossrefPubMedGoogle Scholar
  • 4 Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation-homology with human CD36. J Biol Chem 1993; 268: 17665-17668
    PubMedGoogle Scholar
  • 5 Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80: 1105-1115
    PubMedGoogle Scholar
  • 6 Nakata N, Furukawa K, Greenwalt DE, Sato T, Kobata A. Structural study of the sugar chains of CD36 purified from bovine mammary epithelial cells: occurrence of novel hybrid-type sugar chains containing the Neu5Ac alpha 26GalNAc beta l→4 GlcNAc and the Man alpha 1→2Man alpha 1→3Man alpha 1→6Man groups. Biochemistry 1993; 32: 4369-4383
    CrossrefPubMedGoogle Scholar
  • 7 Kieffer N, Bettaieb A, Legrand C, Coulombel L, Vainchenker W, Edelman L, Breton-Gorius J. Developmentally regulated expression of 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor. Biochem J 1989; 262: 835-842
    CrossrefPubMedGoogle Scholar
  • 8 Yesner LM, Huh HY, Pearce SFA, Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vase Biol 1995; 16: 1019-1025
    PubMedGoogle Scholar
  • 9 Huh HY, Lo SK, Yesner LM, Silverstein RL. CD36 induction on human monocytes upon adhesion to tumor necrosis factor-activated endothelial cells. J Biol Chem 1995; 270: 6267-6271
    CrossrefPubMedGoogle Scholar
  • 10 Knowles DM, Tolidjian B, Marboe C, Agati VD, Grimes M, Chass L. Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distributions including differential reactivity with vascular endothelium. J Immunol 1984; 132: 2170-2213
    PubMedGoogle Scholar
  • 11 Swerlick RA, Lee KH, Wick TM, Lawley TJ. Human dermal micro-vascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992; 148: 78-83
    PubMedGoogle Scholar
  • 12 Amersilla AL, Calvo D, Vega MA. Structural and functional characterisation of the human CD36 gene promoter -Identification of a proximal PEBP2/CBF site. J Biol Chem 1996; 271: 7781-7787
    CrossrefPubMedGoogle Scholar
  • 13 König H, Pfisterer P, Corcoran LM, Wirth T. Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev 1995; 9: 1598-1607
    CrossrefPubMedGoogle Scholar
  • 14 Asch A. To tell the truth: Will the real CD36 please stand up?. J Lab Clin Med 1996; 127: 321-325
    CrossrefPubMedGoogle Scholar
  • 15 Silverstein RL, Asch AS, Nachman RL. Glycoprotein IV mediates thrombospondin-dependentplatelet-monocyte and platelet-11937 cell adhesion. J Clin Invest 1989; 84: 546-552
    CrossrefPubMedGoogle Scholar
  • 16 Silverstein RL, Baird M, Lo SK, Yesner LM. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. J Biol Chem 1992; 267: 16607-16612
    PubMedGoogle Scholar
  • 17 McGregor JL, Catimel B, Parmentier S, Clezardin P, Dechavanne M, Leung LL. Rapid purification and partial characterization of human platelet glycoprotein IIIb-Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem 1989; 264: 501-506
    PubMedGoogle Scholar
  • 18 Leung LLK, Li WX, McGregor JL, Albrecht G, Howard RJ. CD36 peptides enhance or inhibit CD36-thrombospondin binding. J Biol Chem 1992; 267: 18244-18250
    CrossrefPubMedGoogle Scholar
  • 19 Li WX, Howard RJ, Leung LLK. Identification of SVTCG in thrombospondin as the conformation-dependant, high affinity binding site for its receptor, CD36. J Biol Chem 1993; 268: 16179-16184
    PubMedGoogle Scholar
  • 20 Asch AS, Liu I, Bricetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science 1993; 262: 1436-1440
    CrossrefPubMedGoogle Scholar
  • 21 Hatmi M, Garavet JM, Elalamy I, Vargaftig BB, Jacquemin C. Evidence for cAMP-dependent platelet ectoprotein kinase activity that phosphorylates platelet glycoprotein IV (CD36). J Biol Chem 1996; 271: 24776-24780
    CrossrefPubMedGoogle Scholar
  • 22 Tandon NN, Kralisz U, Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264: 7576-7583
    PubMedGoogle Scholar
  • 23 Diazricart M, Tandon NN, Gomezortiz G, Carretero M, Escolar G, Ordinas A, Jamieson GA. Antibodies to CD36 (GPIV) inhibit platelet adhesion to subendothelial surfaces under flow conditions. Arterioscler Thromb Vase Biol 1996; 16: 883-888
    CrossrefPubMedGoogle Scholar
  • 24 Mercier N, Catimel B, Reck MP, Pellechia D, McGregor JL. Identification of a functional site on CD36 involved in the interaction between platelets and collagen. Platelets 1995; 6: 139-145
    CrossrefPubMedGoogle Scholar
  • 25 Barnwell J, Ockenhouse CF, Knowles DM. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and CD32 melanoma cells. J Immunol 1985; 135: 3494-3497
    PubMedGoogle Scholar
  • 26 Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay JD. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science 1989; 243: 1469-1471
    CrossrefPubMedGoogle Scholar
  • 27 Barnwell JW, Asch AS, Nachman RL, Yamaya M, Aikawa M, Ingravallo P. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest 1989; 84: 765-772
    CrossrefPubMedGoogle Scholar
  • 28 Daviet L, Craig AG, McGregor L, Pinches R, Wild TF, Berendt AR, Newbold Cl, McGregor JL. Characterization of two vac-cinia-CD36 recombinant virus generated monoclonal antibodies (10/5,13/10): Effects on malarial cytoadherence and platelet functions. Eur J Biochem. 1997. (in press).
    Google Scholar
  • 29 Daviet L, Buckland R, Puente Navazo MD, McGregor JL. Identification of an immunodominant, functional domain on human CD36 using human-mouse chimeric proteins and homo-logue replacement mutagenesis. Biochem J 1995; 305: 221-224
    CrossrefPubMedGoogle Scholar
  • 30 Cooke BM, Berendt AR, Craig AG, McGregor JL, Newbold Cl, Nash GB. Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for IC AM-1, CD36 and thrombospondin. Br J Haematol 1994; 87: 162-170
    CrossrefPubMedGoogle Scholar
  • 31 Ockenhouse CF, Tegoshi T, Maeno Y, Benjamin C, Ho M, Kan KE, Thway Y, Win K, Aikawa M, Lobb RR. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med 1992; 176: 1183-1189
    CrossrefPubMedGoogle Scholar
  • 32 Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peterson DS, Ravetch JA, Wellems TE. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 1995; 82: 089-100
    CrossrefPubMedGoogle Scholar
  • 33 Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M, Taraschi TF, Howard RJ. Qoning of P.falciparum gene encoding PfEMPl, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 1995; 82: 77-87
    CrossrefPubMedGoogle Scholar
  • 34 Smith ID, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Peterson DS, Pinches R, Newbold C, Miller LH. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 1995; 82: 101-110
    CrossrefPubMedGoogle Scholar
  • 35 Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268: 11811-11816
    PubMedGoogle Scholar
  • 36 Puente Navazo MD, Daviet L, Ninio E, McGregor JL. Identification on human CD36 of a domain implicated in binding oxidised low density lipoproteins. Arterioscler Thromb Vase Biol 1996; 16: 1033-1039
    CrossrefPubMedGoogle Scholar
  • 37 Nicholson AC, Pearce SFA, Silverstein RL. Oxidized LDL binds CD36 on human monocyte-derived macrophages and transfected cell lines - Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vase Biol 1995; 15: 269-275
    CrossrefPubMedGoogle Scholar
  • 38 Greenwalt DE, Scheck SH, Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest 1995; 96: 1382-1388
    CrossrefPubMedGoogle Scholar
  • 39 Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994; 269: 21003-21009
    PubMedGoogle Scholar
  • 40 Huh HY, Pearce SF, Yesner LM, Schindler JL, Silvrstein RL. Regulated expression of CD36 during monocyte-to-macrophage differenciation: Potential role of CD36 in foam cell formation. Blood 1996; 87: 2020-2028
    PubMedGoogle Scholar
  • 41 Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271: 518-520
    CrossrefPubMedGoogle Scholar
  • 42 Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993; 14: 131-136
    CrossrefPubMedGoogle Scholar
  • 43 Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-1449
    CrossrefPubMedGoogle Scholar
  • 44 Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992; 90: 1513-1522
    CrossrefPubMedGoogle Scholar
  • 45 Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 4029-4035
    PubMedGoogle Scholar
  • 46 Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995; 181: 1857-1862
    CrossrefPubMedGoogle Scholar
  • 47 Puente Navazo MD, Daviet L, Ren Y, Savill J, McGregor JL. Identification of a domain on CD36 implicated in the phagocytosis of apoptotic PMN. J Biol Chem 1996; 271: 15381-1535
    CrossrefPubMedGoogle Scholar
  • 49 Rigotti A, Acton SL, Krieger M. The class B scavenger receptor SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995; 270: 16221-16224
    CrossrefPubMedGoogle Scholar
  • 50 Ryeom SW, Silverstein RL, Scotto A, Sparrow JR. Binding of anionic phospholipids to retinal pigment endothelium may be mediated by the scavenger receptor CD36. J Biol Chem 1996; 271: 20536-20539
    CrossrefPubMedGoogle Scholar
  • 51 Franc NC, Dimarcq JL, Lagueux M, Hoffman J, Ezekowitz RAB. Croquemort, a novel Drosophilia hemocyte/macrophage receptor that recognizes apoptotic cells. Immunity 1996; 4: 431-443
    CrossrefPubMedGoogle Scholar
  • 52 Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K. SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 1996; 222: 246-250
    CrossrefPubMedGoogle Scholar
  • 53 Hart K, Wilcox M. A Drosophila gene encoding an epithelial membrane protein with homology to CD36/LIMP-IL. J Mol Biol 1993; 234: 249-253
    CrossrefPubMedGoogle Scholar
  • 54 Ockenhouse CF, Magowan C, Chulay JD. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest 1989; 84: 468-475
    CrossrefPubMedGoogle Scholar
  • 55 Aiken ML, Ginsbeig MH, Byers-Ward V, Plow EF. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood 1990; 76: 2501-2509
    PubMedGoogle Scholar
  • 56 Schüepp BJ, Pfister H, Clemetson KJ, Silverstein RL, Jungi TW. CD36-mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognizing cell membrane-bound thrombospondin. Biochem Biophys Res Commun 1991; 175: 263-270
    CrossrefPubMedGoogle Scholar
  • 57 Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 1991; 88: 7844-7848
    CrossrefPubMedGoogle Scholar
  • 58 Yamamoto N, Akamatzu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994; 83: 392-397
    PubMedGoogle Scholar
  • 59 Kashiwagi H, Honda S, Tomiyama Y, Mizutani H, Take H, Honda Y, Kosugi S, Kanayama Y, Kurata Y, Matsuzawa Y. A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV deficiency. Thromb Haemost 1993; 69: 481-484
    Article in Thieme ConnectPubMedGoogle Scholar
  • 60 Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, Sekiguchi S, Kanayama Y, Kurata Y, Matsuzawa Y. Molecular basis of CD36 deficiency-Evidence that a478C→T substitution (Proline 90→Serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 1995; 95: 1040-1046
    CrossrefPubMedGoogle Scholar
  • 61 Kashiwagi H, Tomiyama Y, Nozaki S, Honda S, Kosugi S, Shiraga M, Nakagawa T, Nagao N, Kanakura Y, Kurata Y, Matsuzawa Y. A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler Thromb Vase Biol 1996; 16: 1026-1032
    CrossrefPubMedGoogle Scholar
  • 62 Daviet L, Morel-Kopp MC, Kaplan C, McGregor JL. A structural/functional domain on human CD36 is involved in the binding of anti-Naka antibodies. Thromb Haemostas 1995; 73: 5435
    PubMedGoogle Scholar
  • 63 Tandon NN, Ockenhouse CF, Greco NJ, Jamieson GA. Adhesive functions of platelets lacking glycoprotein IV (CD36). Blood 1991; 78: 2809-2813
    PubMedGoogle Scholar
  • 64 Kehrel B, Kronenberg A, Schwippert B, Niesing-Bresch D, Niehues U, Tschope D, van de Loo J, Clemetson KJ. Thrombospondin binds normally to glycoprotein Illb deficient platelets. Biochem Biophys Res Commun 1991; 179: 985-991
    CrossrefPubMedGoogle Scholar
  • 65 Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa JI, Kameda-Takemura K, Kurata Y, Matsuzawa Y. Reduced uptake of oxidized low density lipoprotein in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 1995; 96: 1859-1865
    CrossrefPubMedGoogle Scholar